Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Startup HeliTec Launches Large Liquid Biopsy Study

NEW YORK (GenomeWeb) – A Shenzhen, China-based precision cancer sequencing startup called HeliTec announced this week that it is teaming up with the Zhongshan People's Cancer Institute (ZPHCI) to launch a large scale, early cancer detection study based on a liquid biopsy and next-generation sequencing method.

The team plans to tap ZPHCI's large collection of blood samples, collected since 2010 from individuals in a high-risk population in China's Guandong region. The set reportedly includes longitudinal blood samples taken every six months from more than 60,000 adults, as well as detailed patient health records containing information on physical exams, treatments, and follow-up that was done over the years.

Using HeliTec's parallel amplification numerically optimized sequencing (PANO-Seq) platform, the investigators will search for SNPs, small insertions and deletions, copy number alterations, gene fusions, and transcripts present in the blood that may have ties to cancers diagnosed in these individuals over the past seven years or in the future.

In a statement, ZPHCI Director Mingfang Ji said the approach is "like taking a snapshot" every six months, "so that when something is wrong we can go back to the past and find out exactly what has changed."

Along with clues from circulating tumor DNA in the blood, the approach is expected to provide insights into other "rich information hidden in the blood" from tumor RNAs to circulating T-cell receptors repertoires related to tumor neoantigens, according to HeliTec Chief Technology Officer Li Chen.

HeliTec was founded last spring by researchers specialized in cancer and/or next-generation sequencing fields.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.